Cached score snapshot

US.HUM · Humana

110分制 46.5/110；5D動能v2 4/50；排序分 50.5/160

Back to ranking Open volume snapshot

Ranking score 50.5/160

Main score 46.5/110

5D momentum v2 4/50

Rank #392

Setup grade F 19.5

Score breakdown

避免

Elevated twelvedata

Score and price trend

F 19.5 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.297 · anchors 120	+1.12%	-1.18% / +4.23%	61.6%	4.7%	Actual -6.14% · vs median -7.26% · inside 25-75 band
30D observation	+5.19%	-2.88% / +11.57%	68.8%	17.5%	Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160	+0.56%	-1.52% / +4.55%	60%	3.8%	Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-04-29 → 2026-09-04 · 264 archived points · 1 Improving turn signal · 8 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 50.5

Display grade 避免

Model version cursor_18_27_news_v2_160

Main score 46.5/110 (避免)

5D momentum v2 4/50 (弱)

Score with momentum v2 50.5/160 (低排序)

Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60

ma20 397.0435

ma50 360.8916

close 389.32

prevClose 394.5

avgVolume20 1318230

volumeRatio 0.56

changePercent -1.31

Metrics snapshot

close 389.32

volume 740300

changePercent -1.31

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 46.5/110

Main rating 避免

5D momentum v2 4/50

Score with momentum v2 50.5/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.8/5 · 較差

Dimension score 2.8/5

Dimension grade 較差

Sub-items

pbPoints 0.4

pePoints 0.2

epsPoints 0

roePoints 0

debtPoints 0.5

marginPoints 0

turnoverUsdM 288.2136

volumePoints 0.5

revenuePoints 0.4

dividendPoints 0.3

marketCapPoints 0.5

資金流 — 6.8/20 · 較差

Dimension score 6.8/20

Dimension grade 較差

Sub-items

cmfPoints 1.6

mfiPoints 0.8

obvPoints 1.6

vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.HUM

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 5.4/15 · 較差

Dimension score 5.4/15

Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred

vixClose 18.7

trend

score 0.8

details

qqq

ma20 711.713

ma50 718.2872

name QQQ

close 684.23

points 0.4

spy

ma20 746.153

ma50 745.068

name SPY

close 738.93

points 0.4

source twelvedata+fred

atrPct 3.5762

atrPoints 2

cciPoints 0.8

vixPoints 1.8

marketTrendPoints 0.8

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model

articleCount 8

catalystCount 0

catalystPoints 2

風險管理 — 5.9/10 · 較差

Dimension score 5.9/10

Dimension grade 較差

Sub-items

position

score 1.3

details

atrPct 3.5762

turnoverUsdM 288.2136

liquidityPoints 0.6

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.HUM

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 361.4742

strength_details

ma_score 1.5

atr_score 1

rsi_score 1

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 7.2

take_profit_price 408.786

target_multiplier 1.6

technical_strength 1.22

take_profit_percent 5

positionPoints 1.3

stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 7.1524

diversificationPoints 2

技術信號 — 17.6/30 · 較差

Dimension score 17.6/30

Dimension grade 較差

Sub-items

bbPoints 2.4

adxPoints 3

sarPoints 1.2

vcpPoints 1.5

macdPoints 2.4

vcpPayload

vcp_pass false

vcp_score 1.5

vcp_reason 跌縮量(近10日3日)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=N

vcp_metrics

up_days 5

vol_ref 1440810

down_days 4

vcp_ready false

above_ma50 true

avg_vol_10 1346350

avg_vol_20 1338770

avg_vol_30 1440810

range_pct_10 0.1121

range_pct_20 0.1806

range_pct_30 0.1947

up_expand_ok true

lookback_used 59

near_20d_high false

contraction_ok false

down_shrink_ok true

up_expand_days 2

breakout_20d_ok false

vol_ratio_10_30 0.9344

dist_to_20d_high 0.0922

down_shrink_days 3

breakout_level_20d 428.88

vcp_breakout_confirm false

contraction_ratio_10_30 0.5758

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction false

kdjAdxPoints 0.5

rsiKdjPoints 2.4

volumeWeight 2

maCrossPoints 1.6

shortRsiPoints 0.8

shortMacdPoints 0.4

volConfirmPoints 1

volumePointsTechnical 0.4

情緒分析 — 6/10 · 一般

Dimension score 6/10

Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model

articleCount 8

negativeHits 0

positiveHits 4

sentimentScoreRaw 1.2

sentimentData

raw {"id":140983296,"url":"https://finnhub.io/api/news?id=2f88f7edb241eee023f490969f9596d7234726429243eaa176e8d9452e28ecde","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784728817,"headline":"Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?"}, {"id":140973550,"url":"https://finnhub.io/api/news?id=581d7ae2f0ed8441fe2ddce2539424bfd1dc642f82930dcd4b0aff3348adf712","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.","category":"company","datetime":1784649602,"headline":"Humana (HUM) is a Great Momentum Stock: Should You Buy?"}, {"id":140943913,"url":"https://finnhub.io/api/news?id=8fd449448850298f62e831c5153f5e7b5eeba6e698856c04f71fea7a48da00d8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock’s analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within a Medical HMO industry that has itself risen meaningfully this year, highlights growing confidence in Humana’s business relative to peers. Now we will explore how this stronger...","category":"company","datetime":1784387510,"headline":"Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?"}, {"id":140933182,"url":"https://finnhub.io/api/news?id=90fc7fee0402e1dc63ffe5138a2d11e510b6b842fcfad964500c5daabf553e41","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.","category":"company","datetime":1784295649,"headline":"Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?"}, {"id":140922832,"url":"https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.","category":"company","datetime":1784218802,"headline":"Can Humana (HUM) Run Higher on Rising Earnings Estimates?"}, {"id":140906296,"url":"https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...","category":"company","datetime":1784095786,"headline":"Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"}, {"id":140893488,"url":"https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499","image":"","source":"Fintel","related":"HUM","summary":"","category":"company","datetime":1783995721,"headline":"Wells Fargo Upgrades Humana (HUM)"}, {"id":140844596,"url":"https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...","category":"company","datetime":1783538028,"headline":"Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"}

raw_source {"id":141024010,"url":"https://finnhub.io/api/news?id=2c5db92c8ab827ee6f3b90cbf33fde6ea6c56be2eb02d39168027e8407bb46f0","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/803420378/image_803420378.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"The series targets generating 12â15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strategy here.","category":"company","datetime":1785053700,"headline":"Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)"}, {"id":141010762,"url":"https://finnhub.io/api/news?id=34cf0495c3aad32ad59c71b73880c9d0cf75062d6a008f74ecd1fff6c757b090","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.","category":"company","datetime":1784926584,"headline":"The Real Price of UnitedHealth Stock Is Two Years Away"}, {"id":141007777,"url":"https://finnhub.io/api/news?id=ec70fca7d4366d7d7666d1585311865e707df9f66c2e2a1ea1135a70b6f4f642","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.","category":"company","datetime":1784911140,"headline":"Can Humana Beat Q2 Earnings Estimates on Growing Premiums?"}, {"id":140997787,"url":"https://finnhub.io/api/news?id=62fce0608d45e410c0de9b5328f24b3e6e5af974a2273c77868794b05275e66a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.","category":"company","datetime":1784830020,"headline":"MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised"}, {"id":140984930,"url":"https://finnhub.io/api/news?id=fa3b0d57e25d8e6cb4497512fc0df9a3d95b9be42b23bd96dc0f8bf250b2e539","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.","category":"company","datetime":1784734860,"headline":"Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates"}, {"id":140983295,"url":"https://finnhub.io/api/news?id=03ef70f48439c08cb657f244d062289c23c93721dae9698fffbc05e182674506","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company","category":"company","datetime":1784729142,"headline":"Healthcare Services Group Q2 Earnings Call Highlights"}, {"id":140983296,"url":"https://finnhub.io/api/news?id=2f88f7edb241eee023f490969f9596d7234726429243eaa176e8d9452e28ecde","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784728817,"headline":"Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?"}, {"id":140983761,"url":"https://finnhub.io/api/news?id=96be1c9a57931cb47d1e6d9d1241589e4644addd7b819db5dfae61b589c0610f","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340690121/image_1340690121.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions.","category":"company","datetime":1784723700,"headline":"Nomura Core Equity Fund Q2 2026 Portfolio Review"}, {"id":140976384,"url":"https://finnhub.io/api/news?id=57236c5052f85582eb5ea0f555f013f41560f1273e2f5734bc67c62a45028091","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.","category":"company","datetime":1784669171,"headline":"The Hidden Engine Behind Elevance Health Stock's Next Climb"}, {"id":140976385,"url":"https://finnhub.io/api/news?id=82aea808c7ba6dd8cc4c52c74c0cbb24ac81eca4dffdd8eaae25d25ec6adcf2e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.","category":"company","datetime":1784665995,"headline":"What Kept Coming Up When Analysts Grilled UNH"}, {"id":140973550,"url":"https://finnhub.io/api/news?id=581d7ae2f0ed8441fe2ddce2539424bfd1dc642f82930dcd4b0aff3348adf712","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.","category":"company","datetime":1784649602,"headline":"Humana (HUM) is a Great Momentum Stock: Should You Buy?"}, {"id":140973836,"url":"https://finnhub.io/api/news?id=e98bbcd3c40e9eb1c069bf812abf8cb1de619dd38fa0d0df460fe4f786bb9509","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will","category":"company","datetime":1784640912,"headline":"10 Health Care Stocks With Whale Alerts In Today’s Session"}, {"id":140964592,"url":"https://finnhub.io/api/news?id=58f2422d303d8abfa6b6a25d4132328b6a814c3f9522481f3742d3a550f5e74e","image":"https://cdn.benzinga.com/files/images/story/2026/07/20/Medicare-Advantage.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older","category":"company","datetime":1784568273,"headline":"2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027"}, {"id":140960646,"url":"https://finnhub.io/api/news?id=26611f7250ba7764b0a74ecf69e8ba7e9451005d8c6eacbd3be4626ede25f15c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.","category":"company","datetime":1784558582,"headline":"The Real Risk Inside UnitedHealth Stock"}, {"id":140943913,"url":"https://finnhub.io/api/news?id=8fd449448850298f62e831c5153f5e7b5eeba6e698856c04f71fea7a48da00d8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock’s analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within a Medical HMO industry that has itself risen meaningfully this year, highlights growing confidence in Humana’s business relative to peers. Now we will explore how this stronger...","category":"company","datetime":1784387510,"headline":"Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?"}, {"id":140939166,"url":"https://finnhub.io/api/news?id=abb851b8ee2d464a110b910c89dadec490fc80b6db6ddf24abbb5c7ae870adf5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.","category":"company","datetime":1784326192,"headline":"What A Patient Holder Is Really Paying For CVS Health Stock"}, {"id":140939174,"url":"https://finnhub.io/api/news?id=50dc6e76d1c3aa89467680e6bc1cf51c7a2b8faf7bea9022ea161510d8c648b1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.","category":"company","datetime":1784325720,"headline":"What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?"}, {"id":140935745,"url":"https://finnhub.io/api/news?id=66569f4b63aaf34234d1daceaa2b07b4c21c46e1e9988c5dc64bf093a47bc25f","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"HUM","summary":"Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.","category":"company","datetime":1784315101,"headline":"Discover which S&P500 stocks are making waves on Friday."}, {"id":140933182,"url":"https://finnhub.io/api/news?id=90fc7fee0402e1dc63ffe5138a2d11e510b6b842fcfad964500c5daabf553e41","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.","category":"company","datetime":1784295649,"headline":"Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?"}, {"id":140935380,"url":"https://finnhub.io/api/news?id=054ef16715c2a066d23ceec191ec59e5627f1a6a8b52cd36e1ae193044741afe","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1784295319,"headline":"4 Health Care Stocks Whale Activity In Today’s Session"}, {"id":140926098,"url":"https://finnhub.io/api/news?id=a3ed218800a97680c73e07aa6bb488836ce3c983719dca490e71b4cd424977f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.","category":"company","datetime":1784233476,"headline":"UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates"}, {"id":140924354,"url":"https://finnhub.io/api/news?id=6beff7ff98afeafc7e69e28d5375177dc8b70c8486507b5409de1426713e60de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs, sending the Dow Jones stock surging past a buy point on Thursday morning. Rival managed-care providers including Humana, Centene and Elevance Health got a sizable lift from the initial warm reception for UnitedHealth's earnings report. Results: UnitedHealth posted Q2 earnings per share of $6.38, up 56% from a weak year-earlier result and 30% ahead of $4.91 forecasts.","category":"company","datetime":1784230057,"headline":"Why UNH Stock Breakout Faltered After Massive Earnings Beat"}, {"id":140922832,"url":"https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.","category":"company","datetime":1784218802,"headline":"Can Humana (HUM) Run Higher on Rising Earnings Estimates?"}, {"id":140921098,"url":"https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.","category":"company","datetime":1784213644,"headline":"UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"}, {"id":140920951,"url":"https://finnhub.io/api/news?id=4edc50fb0c0b3163368a3ac06c10ca151d88a91c32421f42358d93e3f325254f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.","category":"company","datetime":1784211300,"headline":"Sandisk, Micron, TSMC, UnitedHealth, and More Stocks That Explain Today’s Market"}, {"id":140923118,"url":"https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103","image":"https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.","category":"company","datetime":1784208257,"headline":"UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"}, {"id":140919761,"url":"https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.","category":"company","datetime":1784207995,"headline":"The Medicaid Problem That Swallowed an Earnings Beat"}, {"id":140919767,"url":"https://finnhub.io/api/news?id=5bce92d51784c68c7f17ff30ac90cfadc42527df5e6f98bcf7d33ff3a800eb62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.","category":"company","datetime":1784205720,"headline":"Inside the UnitedHealth Earnings Beat That Lifted Healthcare Stocks"}, {"id":140919291,"url":"https://finnhub.io/api/news?id=195f8e2045a457bd41c82088ca85aafdc16620b26b540f6e0008b4d2a9b08064","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"HUM","summary":"The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.","category":"company","datetime":1784205300,"headline":"What's going on in today's pre-market session: S&P500 movers"}, {"id":140919768,"url":"https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.","category":"company","datetime":1784205032,"headline":"The Medicaid Problem Weighing On Elevance Health Stock"}, {"id":140919728,"url":"https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.","category":"company","datetime":1784205031,"headline":"The Real Price of Admission for CVS Health Stock"}, {"id":140919679,"url":"https://finnhub.io/api/news?id=54e2d3441d9dc3c895613df0f8f0e6192543381b162933236b00e7b8c37b72f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.","category":"company","datetime":1784204340,"headline":"Sandisk, UnitedHealth, J.B. Hunt, TSMC, and More Stocks That Explain Today’s Market"}, {"id":140920007,"url":"https://finnhub.io/api/news?id=b05572daf0c4b7738b01cacb08bf0110183587e578a16a35f389f0c74c58a89a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth (UNH) delivered earnings and revenue surprises of +29.15% and +1.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1784199902,"headline":"UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates"}, {"id":140918841,"url":"https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.","category":"company","datetime":1784199650,"headline":"UNH Stock Flashes Buy Signal On Massive Earnings Beat"}, {"id":140918843,"url":"https://finnhub.io/api/news?id=cf5cb36802c45abb2a183490e32f65c7eec1280c026b62d4e243a0196161334b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.","category":"company","datetime":1784198280,"headline":"UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost"}, {"id":140923188,"url":"https://finnhub.io/api/news?id=d85d188ac31f0be7b67de702da053ebe6f33ee097b1395995d39e56ab6610ae9","image":"https://cdn.benzinga.com/files/images/story/2026/07/16/GLP-1.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you","category":"company","datetime":1784193389,"headline":"Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027"}, {"id":140914116,"url":"https://finnhub.io/api/news?id=e9db35be5692d32311636bfb2d472068853dd38721681a09228157e8ca04b9d7","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1163752700/image_1163752700.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"Humana stock surged 106% on Medicare Advantage optimism, but margins and earnings lag and valuation looks stretched. Click for more on HUM stock.","category":"company","datetime":1784137230,"headline":"Humana: Q2 Earnings Must Catch Up With The Stock"}, {"id":140907461,"url":"https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.","category":"company","datetime":1784114481,"headline":"Insurance stocks fall after Elevance Health results show margin pressure"}, {"id":140906296,"url":"https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...","category":"company","datetime":1784095786,"headline":"Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"}, {"id":140901947,"url":"https://finnhub.io/api/news?id=5f3fef99ff0df0cac06252e71b332ffd16257eb940089d3f03c9ff846d60da6c","image":"","source":"Benzinga","related":"HUM","summary":"TD Cowen analyst Ryan Langston maintains Humana (NYSE:HUM) with a Hold and raises the price target from $211 to $350.","category":"company","datetime":1784028528,"headline":"TD Cowen Maintains Hold on Humana, Raises Price Target to $350"}, {"id":140901948,"url":"https://finnhub.io/api/news?id=3c52092a2a30d09e2f4291941a91a1161fec0a8e29e89d8fa52bd0d1ff2215ef","image":"","source":"Benzinga","related":"HUM","summary":"Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $320 to $415.","category":"company","datetime":1784021510,"headline":"Truist Securities Maintains Hold on Humana, Raises Price Target to $415"}, {"id":140893488,"url":"https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499","image":"","source":"Fintel","related":"HUM","summary":"","category":"company","datetime":1783995721,"headline":"Wells Fargo Upgrades Humana (HUM)"}, {"id":140890161,"url":"https://finnhub.io/api/news?id=e25110c78ca2177615e41497f4272b141937d60a5e1b269003abf9d7270f7d7c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and","category":"company","datetime":1783971281,"headline":"Sector Update: Healthcare Stocks Advance Late Afternoon"}, {"id":140890023,"url":"https://finnhub.io/api/news?id=495aea92af0bbd7e19a383216dfbd22c522dee63025845643456bbfaa14d3c16","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.","category":"company","datetime":1783965840,"headline":"Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch"}, {"id":140890002,"url":"https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.","category":"company","datetime":1783965262,"headline":"The Premium On CVS Stock Vs What Its Peers Deliver"}, {"id":140888416,"url":"https://finnhub.io/api/news?id=fd4d4d323ca3fedefea2cc6d440ffd8cf63824e0800c451fe6d924a57bcada11","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.","category":"company","datetime":1783960620,"headline":"Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?"}, {"id":140885931,"url":"https://finnhub.io/api/news?id=d9bd3e5a447e59b21f811bc30301952ad049da7bb5153d18da437fe995ccd6e2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"American Express, Biogen upgraded: Wall Street's top analyst calls","category":"company","datetime":1783950101,"headline":"American Express, Biogen upgraded: Wall Street's top analyst calls"}, {"id":140888858,"url":"https://finnhub.io/api/news?id=2ee353ba4819573ae59d8207240fe4802587c3ae7f9647c9333653e00912cd13","image":"","source":"Benzinga","related":"HUM","summary":"Wells Fargo analyst Stephen Baxter upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $227 to $502.","category":"company","datetime":1783929218,"headline":"Wells Fargo Upgrades Humana to Overweight, Raises Price Target to $502"}, {"id":140865405,"url":"https://finnhub.io/api/news?id=43b032537d5346775647011af917abc702bf8a42f9ad7ce1513fce3cdf3d5099","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.","category":"company","datetime":1783707000,"headline":"Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?"}, {"id":140864271,"url":"https://finnhub.io/api/news?id=2e1f4d2e2bd8a771190b14a8e47325fa8f08b3d3b73ff3f485a97a763923bec7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.","category":"company","datetime":1783700700,"headline":"Is ELV's Capital Allocation Strategy Creating Long-Term Value?"}, {"id":140864272,"url":"https://finnhub.io/api/news?id=8cb9ceee7f486eaba0b4c7d9e75a7a6713c50af11938b8057df4ec2e73f044c6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.","category":"company","datetime":1783700580,"headline":"Can UNH's Lifestyle Spending Account Redefine Employee Benefits?"}, {"id":140861604,"url":"https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.","category":"company","datetime":1783684540,"headline":"UNH Showered Owners With Cash. The Stock Did Not Cooperate"}, {"id":140860584,"url":"https://finnhub.io/api/news?id=b0b89f578c00f4ef5ee36881a23109c43fd7c57d2231e57e1adfbc28747b77a6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16","category":"company","datetime":1783683039,"headline":"The Main Reason Behind Buying UnitedHealth Before July 16"}, {"id":140860865,"url":"https://finnhub.io/api/news?id=3534cd0756dbc13bd4612d305a212cd65ae36ef9141d04b1b4365039c50b020f","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1278842473/image_1278842473.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"The S&P 500 declined 0.95% as market leadership rotated away from mega-cap tech. Read more here.","category":"company","datetime":1783671000,"headline":"Broadening Market Lifts Moat Stocks In June"}, {"id":140854725,"url":"https://finnhub.io/api/news?id=4d4ba33028b72345771b2d6177ef4a48ef6331e93a1f3ef095b421cf04b71092","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”","category":"company","datetime":1783622061,"headline":"Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”"}, {"id":140851085,"url":"https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.","category":"company","datetime":1783604827,"headline":"The Real Price of UnitedHealth Stock Isn't on Today's Label"}, {"id":140865176,"url":"https://finnhub.io/api/news?id=b5b0d6d80e9f8fc9b7209c25c2b2b814f79658f1aba834769155c9e2eafae44d","image":"","source":"Benzinga","related":"HUM","summary":"RBC Capital analyst Ben Hendrix maintains Humana (NYSE:HUM) with a Sector Perform and raises the price target from $246 to $415.","category":"company","datetime":1783603928,"headline":"RBC Capital Maintains Sector Perform on Humana, Raises Price Target to $415"}, {"id":140844596,"url":"https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...","category":"company","datetime":1783538028,"headline":"Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"}, {"id":140843416,"url":"https://finnhub.io/api/news?id=5dd1d143f06f4fa4eb3d3a97880fa22ffc1c5de99e6a64d0a7dcb18a4055d14a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.","category":"company","datetime":1783524300,"headline":"UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?"}, {"id":140834545,"url":"https://finnhub.io/api/news?id=2b9ad6b049d73243c2c7d8cc8764c34538c16d53083e94ef5b89809c55698234","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.","category":"company","datetime":1783430767,"headline":"Humana Earnings Preview: What to Expect"}, {"id":140830888,"url":"https://finnhub.io/api/news?id=7e0083af50961ff361349709b6916fd6b5d1b8e4b89f6a2ba577c788e6b954a8","image":"","source":"Benzinga","related":"HUM","summary":"Cantor Fitzgerald analyst Sarah James maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $264 to $300.","category":"company","datetime":1783410797,"headline":"Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300"}, {"id":140822476,"url":"https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.","category":"company","datetime":1783354301,"headline":"What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"}, {"id":140819581,"url":"https://finnhub.io/api/news?id=ede26e95f8cd574ded4ee784a40075275bfa1057664adeed1fd210da7b21e2f2","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208348437/image_2208348437.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.","category":"company","datetime":1783327970,"headline":"CVS Health: The Surprising Healthcare Outlier"}, {"id":140807752,"url":"https://finnhub.io/api/news?id=db7dccf806f73313f5852acc19a832bddeba826f9f5173bb131d4479cbbcd12e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]","category":"company","datetime":1783174832,"headline":"Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”"}, {"id":140799596,"url":"https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.","category":"company","datetime":1783081253,"headline":"The Unpopular Move That Telegraphed the Elevance Health Stock Surge"}, {"id":140791579,"url":"https://finnhub.io/api/news?id=8dc403fbee8db8aad1d942b0a90f0ef7b4aed8b012426ecb0dbfe2b55e9d2556","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.","category":"company","datetime":1782999120,"headline":"PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare"}, {"id":140792257,"url":"https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2","image":"https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080","source":"CNBC","related":"HUM","summary":"CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.","category":"company","datetime":1782933515,"headline":"Meta's new cloud business will be instantly profitable, says Jim Cramer"}, {"id":140772839,"url":"https://finnhub.io/api/news?id=6a277ca3b6991ab8e80b88b14bee749319d8ff8f2a6c7597e280f0b5c316b8da","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group (UNH) is likely to report second-quarter earnings above Wall Street's consensus,","category":"company","datetime":1782828758,"headline":"UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says"}, {"id":140772135,"url":"https://finnhub.io/api/news?id=7c0b16820ebd282600b26a580e95b5d32062b8fb552556b1e38962e35c874e2a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., June 30, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.","category":"company","datetime":1782820800,"headline":"The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants"}, {"id":140771643,"url":"https://finnhub.io/api/news?id=933974103b907b1d72be4a7f5132c37cde71a5380376053b69d31f5124d9c4b7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"DarioHealth Corp. (NASDAQ: DRIO) (the \"Company\", \"DarioHealth\" or \"Dario\"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.","category":"company","datetime":1782819000,"headline":"Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships"}, {"id":140774740,"url":"https://finnhub.io/api/news?id=bac1556681a38492c41d8ad99cae5880494ce345262ebc615ded85f7f7858fe6","image":"https://cdn.benzinga.com/files/images/story/2026/06/30/Two-Injectors-Dosing-Pens-For-Subcutaneo.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility and access.","category":"company","datetime":1782808093,"headline":"Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday"}, {"id":140781618,"url":"https://finnhub.io/api/news?id=c2b9cf7db5e8e7b511f80cba972d4339f22d420c6b2bd7054751c0b254645eec","image":"https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080","source":"CNBC","related":"HUM","summary":"The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.","category":"company","datetime":1782795601,"headline":"Medicare will start covering obesity drugs for the first time. Here's what patients should know"}, {"id":140781757,"url":"https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e","image":"https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080","source":"CNBC","related":"HUM","summary":"The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.","category":"company","datetime":1782760725,"headline":"Tuesday's big stock stories: What’s likely to move the market in the next trading session"}, {"id":140762586,"url":"https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.","category":"company","datetime":1782744240,"headline":"How CenterWell Is Driving Humana's Growth Beyond Insurance"}, {"id":140761652,"url":"https://finnhub.io/api/news?id=ec9490d78d2bbdede75602bb26eb289d1c5b1536c79f6283f5756d1080b4670b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.","category":"company","datetime":1782737415,"headline":"2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges"}, {"id":140738020,"url":"https://finnhub.io/api/news?id=21eee8397f16e7d74095ad3cf7e8fc458841490e5fdbb2389cbf7c1ad40e1088","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.","category":"company","datetime":1782488700,"headline":"Can Carelon Drive Elevance Health's Future Earnings Growth?"}, {"id":140739246,"url":"https://finnhub.io/api/news?id=47ec2a2209086a44ad157e6195ed8a0ffc0e3023569ffaf896991b26b1a9e44d","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1782480916,"headline":"4 Health Care Stocks With Whale Alerts In Today’s Session"}

data_source finnhub_news_keyword_model

article_count 8

negative_hits 0

positive_hits 4

recomputed_at_score true

sentiment_score_raw 1.2

source_article_count 77

discarded_article_count 69

sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 2.8 5/110 56% 2.8

資金流 6.8 20/110 34% 6.8

市場環境 5.4 15/110 36% 5.4

催化劑 2 20/110 10% 2

風險管理 5.9 10/110 59% 5.9

技術信號 17.6 30/110 58.67% 17.6

情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 4/50

ret_5d -0.0267

max_score 50

max_total 50

raw_total 4

vcp_bonus 0

vol_ratio 0.553

ret_points 0

vol_points 0

range_ratio 0.8374

volat_points 0

day_range_pct 0.0313

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 4

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Elevated

reason risk management score >= 5/10

position

score 1.3

details

atrPct 3.5762

turnoverUsdM 288.2136

liquidityPoints 0.6

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.HUM

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 361.4742

strength_details

ma_score 1.5

atr_score 1

rsi_score 1

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 7.2

take_profit_price 408.786

target_multiplier 1.6

technical_strength 1.22

take_profit_percent 5

positionPoints 1.3

stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 7.1524

diversificationPoints 2

Calculation audit log

基本面分析總分: 2.8/5分
資金流分析總分: 6.8/20分
市場環境分析總分: 5.4/15分
催化劑分析: 2/20分
風險管理總分: 5.9/10分
技術信號分析總分: 17.6/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 85.71

atr

atr 13.9229

rule ATR / current price; lower volatility scores higher

score 4

atr_pct 3.58

cci

rule Cursor_18.24 CCI bands

level 超買或超賣風險

score 2

value -67.56

cmf

rule Cursor_18.24 CMF bands

level 平衡

score 4

value 0.0466

kdj

d 33.59

j 4.32

k 23.84

rule Cursor_18.24 K/D cross

score 0

signal 死叉

mfi

rule Cursor_18.24 MFI bands

level 超賣或超買風險

score 2

value 34.13

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 4

trend 弱勢

value 23349800

recentSlope -64740

previousSlope 432770

rsi

value 47.89

sar

rule Cursor_18.24 Parabolic SAR

score 4

trend 下降

value 411.6004

position SAR喺價上

distancePct 5.72

previousTrend 下降

ma50

value 360.8916

macd

macd 10.2079

trend 中性偏多

signal 13.957

histogram -3.7491

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 2

value 397.0235

position <VWAP

consecutiveAbove 0

volume

rule Cursor_18.24 volume ratio

level 空升

ratio 0.56

score 2

avgVolume 1318230

currentVolume 740300

derived

ma20 397.0435

ma50 360.8916

prevClose 394.5

avgVolume10 1241550

avgVolume20 1318230

changePercent -1.31

avgVolumeForScore 1318230

ma_cross

ma20 397.0435

ma50 360.8916

rule Cursor_18.24 MA20/MA50 cross

cross 多頭

score 4

prevMa20 396.3775

prevMa50 359.0122

spreadPct 10.02

isVolumeBreakout false

bollinger

lower 383.0929

upper 410.9941

position 中間

rsi_short

value 53.89

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 0.56

Raw calculation JSON

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.576209709847691,
        "turnoverUsdM": 288.213603403,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 361.4742,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7.2,
      "take_profit_price": 408.786,
      "target_multiplier": 1.6,
      "technical_strength": 1.22,
      "take_profit_percent": 5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.152419419695382,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 50.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 397.0435,
    "ma50": 360.8916,
    "close": 389.32,
    "prevClose": 394.5,
    "avgVolume20": 1318230,
    "volumeRatio": 0.56,
    "changePercent": -1.31
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.026699974999999987,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.5529702637495612,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.8373940638859434,
      "volat_points": 0,
      "day_range_pct": 0.031336663121939085,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 50.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 6.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 34,
        "contribution": 6.8
      },
      {
        "raw": 5.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 36,
        "contribution": 5.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 17.6,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58.67,
        "contribution": 17.6
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46.5,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 6.8/20分",
      "市場環境分析總分: 5.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 17.6/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 6.8,
      "市場環境": 5.4,
      "情緒分析": 6,
      "技術信號": 17.6,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 288.213603403,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 0.8,
          "obvPoints": 1.6,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.7
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 711.71300025,
                "ma50": 718.2872022,
                "name": "QQQ",
                "close": 684.22998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.1530053500001,
                "ma50": 745.0680014400001,
                "name": "SPY",
                "close": 738.92999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.576209709847691,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140983296,
                "url": "https://finnhub.io/api/news?id=2f88f7edb241eee023f490969f9596d7234726429243eaa176e8d9452e28ecde",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784728817,
                "headline": "Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?"
              },
              {
                "id": 140973550,
                "url": "https://finnhub.io/api/news?id=581d7ae2f0ed8441fe2ddce2539424bfd1dc642f82930dcd4b0aff3348adf712",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.",
                "category": "company",
                "datetime": 1784649602,
                "headline": "Humana (HUM) is a Great Momentum Stock: Should You Buy?"
              },
              {
                "id": 140943913,
                "url": "https://finnhub.io/api/news?id=8fd449448850298f62e831c5153f5e7b5eeba6e698856c04f71fea7a48da00d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock’s analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within a Medical HMO industry that has itself risen meaningfully this year, highlights growing confidence in Humana’s business relative to peers. Now we will explore how this stronger...",
                "category": "company",
                "datetime": 1784387510,
                "headline": "Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?"
              },
              {
                "id": 140933182,
                "url": "https://finnhub.io/api/news?id=90fc7fee0402e1dc63ffe5138a2d11e510b6b842fcfad964500c5daabf553e41",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1784295649,
                "headline": "Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?"
              },
              {
                "id": 140922832,
                "url": "https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",
                "category": "company",
                "datetime": 1784218802,
                "headline": "Can Humana (HUM) Run Higher on Rising Earnings Estimates?"
              },
              {
                "id": 140906296,
                "url": "https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...",
                "category": "company",
                "datetime": 1784095786,
                "headline": "Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"
              },
              {
                "id": 140893488,
                "url": "https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1783995721,
                "headline": "Wells Fargo Upgrades Humana (HUM)"
              },
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              }
            ],
            "raw_source": [
              {
                "id": 141024010,
                "url": "https://finnhub.io/api/news?id=2c5db92c8ab827ee6f3b90cbf33fde6ea6c56be2eb02d39168027e8407bb46f0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/803420378/image_803420378.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The series targets generating 12â15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strategy here.",
                "category": "company",
                "datetime": 1785053700,
                "headline": "Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)"
              },
              {
                "id": 141010762,
                "url": "https://finnhub.io/api/news?id=34cf0495c3aad32ad59c71b73880c9d0cf75062d6a008f74ecd1fff6c757b090",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.",
                "category": "company",
                "datetime": 1784926584,
                "headline": "The Real Price of UnitedHealth Stock Is Two Years Away"
              },
              {
                "id": 141007777,
                "url": "https://finnhub.io/api/news?id=ec70fca7d4366d7d7666d1585311865e707df9f66c2e2a1ea1135a70b6f4f642",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.",
                "category": "company",
                "datetime": 1784911140,
                "headline": "Can Humana Beat Q2 Earnings Estimates on Growing Premiums?"
              },
              {
                "id": 140997787,
                "url": "https://finnhub.io/api/news?id=62fce0608d45e410c0de9b5328f24b3e6e5af974a2273c77868794b05275e66a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.",
                "category": "company",
                "datetime": 1784830020,
                "headline": "MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised"
              },
              {
                "id": 140984930,
                "url": "https://finnhub.io/api/news?id=fa3b0d57e25d8e6cb4497512fc0df9a3d95b9be42b23bd96dc0f8bf250b2e539",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.",
                "category": "company",
                "datetime": 1784734860,
                "headline": "Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates"
              },
              {
                "id": 140983295,
                "url": "https://finnhub.io/api/news?id=03ef70f48439c08cb657f244d062289c23c93721dae9698fffbc05e182674506",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company",
                "category": "company",
                "datetime": 1784729142,
                "headline": "Healthcare Services Group Q2 Earnings Call Highlights"
              },
              {
                "id": 140983296,
                "url": "https://finnhub.io/api/news?id=2f88f7edb241eee023f490969f9596d7234726429243eaa176e8d9452e28ecde",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784728817,
                "headline": "Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?"
              },
              {
                "id": 140983761,
                "url": "https://finnhub.io/api/news?id=96be1c9a57931cb47d1e6d9d1241589e4644addd7b819db5dfae61b589c0610f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340690121/image_1340690121.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions.",
                "category": "company",
                "datetime": 1784723700,
                "headline": "Nomura Core Equity Fund Q2 2026 Portfolio Review"
              },
              {
                "id": 140976384,
                "url": "https://finnhub.io/api/news?id=57236c5052f85582eb5ea0f555f013f41560f1273e2f5734bc67c62a45028091",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.",
                "category": "company",
                "datetime": 1784669171,
                "headline": "The Hidden Engine Behind Elevance Health Stock's Next Climb"
              },
              {
                "id": 140976385,
                "url": "https://finnhub.io/api/news?id=82aea808c7ba6dd8cc4c52c74c0cbb24ac81eca4dffdd8eaae25d25ec6adcf2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.",
                "category": "company",
                "datetime": 1784665995,
                "headline": "What Kept Coming Up When Analysts Grilled UNH"
              },
              {
                "id": 140973550,
                "url": "https://finnhub.io/api/news?id=581d7ae2f0ed8441fe2ddce2539424bfd1dc642f82930dcd4b0aff3348adf712",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.",
                "category": "company",
                "datetime": 1784649602,
                "headline": "Humana (HUM) is a Great Momentum Stock: Should You Buy?"
              },
              {
                "id": 140973836,
                "url": "https://finnhub.io/api/news?id=e98bbcd3c40e9eb1c069bf812abf8cb1de619dd38fa0d0df460fe4f786bb9509",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1784640912,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140964592,
                "url": "https://finnhub.io/api/news?id=58f2422d303d8abfa6b6a25d4132328b6a814c3f9522481f3742d3a550f5e74e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/20/Medicare-Advantage.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older",
                "category": "company",
                "datetime": 1784568273,
                "headline": "2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027"
              },
              {
                "id": 140960646,
                "url": "https://finnhub.io/api/news?id=26611f7250ba7764b0a74ecf69e8ba7e9451005d8c6eacbd3be4626ede25f15c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.",
                "category": "company",
                "datetime": 1784558582,
                "headline": "The Real Risk Inside UnitedHealth Stock"
              },
              {
                "id": 140943913,
                "url": "https://finnhub.io/api/news?id=8fd449448850298f62e831c5153f5e7b5eeba6e698856c04f71fea7a48da00d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock’s analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within a Medical HMO industry that has itself risen meaningfully this year, highlights growing confidence in Humana’s business relative to peers. Now we will explore how this stronger...",
                "category": "company",
                "datetime": 1784387510,
                "headline": "Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?"
              },
              {
                "id": 140939166,
                "url": "https://finnhub.io/api/news?id=abb851b8ee2d464a110b910c89dadec490fc80b6db6ddf24abbb5c7ae870adf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.",
                "category": "company",
                "datetime": 1784326192,
                "headline": "What A Patient Holder Is Really Paying For CVS Health Stock"
              },
              {
                "id": 140939174,
                "url": "https://finnhub.io/api/news?id=50dc6e76d1c3aa89467680e6bc1cf51c7a2b8faf7bea9022ea161510d8c648b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.",
                "category": "company",
                "datetime": 1784325720,
                "headline": "What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?"
              },
              {
                "id": 140935745,
                "url": "https://finnhub.io/api/news?id=66569f4b63aaf34234d1daceaa2b07b4c21c46e1e9988c5dc64bf093a47bc25f",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.",
                "category": "company",
                "datetime": 1784315101,
                "headline": "Discover which S&P500 stocks are making waves on Friday."
              },
              {
                "id": 140933182,
                "url": "https://finnhub.io/api/news?id=90fc7fee0402e1dc63ffe5138a2d11e510b6b842fcfad964500c5daabf553e41",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1784295649,
                "headline": "Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?"
              },
              {
                "id": 140935380,
                "url": "https://finnhub.io/api/news?id=054ef16715c2a066d23ceec191ec59e5627f1a6a8b52cd36e1ae193044741afe",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1784295319,
                "headline": "4 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 140926098,
                "url": "https://finnhub.io/api/news?id=a3ed218800a97680c73e07aa6bb488836ce3c983719dca490e71b4cd424977f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.",
                "category": "company",
                "datetime": 1784233476,
                "headline": "UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates"
              },
              {
                "id": 140924354,
                "url": "https://finnhub.io/api/news?id=6beff7ff98afeafc7e69e28d5375177dc8b70c8486507b5409de1426713e60de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs, sending the Dow Jones stock surging past a buy point on Thursday morning.  Rival managed-care providers including Humana, Centene and Elevance Health got a sizable lift from the initial warm reception for UnitedHealth's earnings report.  Results: UnitedHealth posted Q2 earnings per share of $6.38, up 56% from a weak year-earlier result and 30% ahead of $4.91 forecasts.",
                "category": "company",
                "datetime": 1784230057,
                "headline": "Why UNH Stock Breakout Faltered After Massive Earnings Beat"
              },
              {
                "id": 140922832,
                "url": "https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",
                "category": "company",
                "datetime": 1784218802,
                "headline": "Can Humana (HUM) Run Higher on Rising Earnings Estimates?"
              },
              {
                "id": 140921098,
                "url": "https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.",
                "category": "company",
                "datetime": 1784213644,
                "headline": "UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"
              },
              {
                "id": 140920951,
                "url": "https://finnhub.io/api/news?id=4edc50fb0c0b3163368a3ac06c10ca151d88a91c32421f42358d93e3f325254f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.",
                "category": "company",
                "datetime": 1784211300,
                "headline": "Sandisk, Micron, TSMC, UnitedHealth, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140923118,
                "url": "https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "UnitedHealth&#39;s (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.",
                "category": "company",
                "datetime": 1784208257,
                "headline": "UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"
              },
              {
                "id": 140919761,
                "url": "https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.",
                "category": "company",
                "datetime": 1784207995,
                "headline": "The Medicaid Problem That Swallowed an Earnings Beat"
              },
              {
                "id": 140919767,
                "url": "https://finnhub.io/api/news?id=5bce92d51784c68c7f17ff30ac90cfadc42527df5e6f98bcf7d33ff3a800eb62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.",
                "category": "company",
                "datetime": 1784205720,
                "headline": "Inside the UnitedHealth Earnings Beat That Lifted Healthcare Stocks"
              },
              {
                "id": 140919291,
                "url": "https://finnhub.io/api/news?id=195f8e2045a457bd41c82088ca85aafdc16620b26b540f6e0008b4d2a9b08064",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1784205300,
                "headline": "What's going on in today's pre-market session: S&P500 movers"
              },
              {
                "id": 140919768,
                "url": "https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.",
                "category": "company",
                "datetime": 1784205032,
                "headline": "The Medicaid Problem Weighing On Elevance Health Stock"
              },
              {
                "id": 140919728,
                "url": "https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.",
                "category": "company",
                "datetime": 1784205031,
                "headline": "The Real Price of Admission for CVS Health Stock"
              },
              {
                "id": 140919679,
                "url": "https://finnhub.io/api/news?id=54e2d3441d9dc3c895613df0f8f0e6192543381b162933236b00e7b8c37b72f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.",
                "category": "company",
                "datetime": 1784204340,
                "headline": "Sandisk, UnitedHealth, J.B. Hunt, TSMC, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140920007,
                "url": "https://finnhub.io/api/news?id=b05572daf0c4b7738b01cacb08bf0110183587e578a16a35f389f0c74c58a89a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) delivered earnings and revenue surprises of +29.15% and +1.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784199902,
                "headline": "UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates"
              },
              {
                "id": 140918841,
                "url": "https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook.  Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.",
                "category": "company",
                "datetime": 1784199650,
                "headline": "UNH Stock Flashes Buy Signal On Massive Earnings Beat"
              },
              {
                "id": 140918843,
                "url": "https://finnhub.io/api/news?id=cf5cb36802c45abb2a183490e32f65c7eec1280c026b62d4e243a0196161334b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.",
                "category": "company",
                "datetime": 1784198280,
                "headline": "UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost"
              },
              {
                "id": 140923188,
                "url": "https://finnhub.io/api/news?id=d85d188ac31f0be7b67de702da053ebe6f33ee097b1395995d39e56ab6610ae9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/GLP-1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you",
                "category": "company",
                "datetime": 1784193389,
                "headline": "Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027"
              },
              {
                "id": 140914116,
                "url": "https://finnhub.io/api/news?id=e9db35be5692d32311636bfb2d472068853dd38721681a09228157e8ca04b9d7",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1163752700/image_1163752700.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana stock surged 106% on Medicare Advantage optimism, but margins and earnings lag and valuation looks stretched. Click for more on HUM stock.",
                "category": "company",
                "datetime": 1784137230,
                "headline": "Humana: Q2 Earnings Must Catch Up With The Stock"
              },
              {
                "id": 140907461,
                "url": "https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.",
                "category": "company",
                "datetime": 1784114481,
                "headline": "Insurance stocks fall after Elevance Health results show margin pressure"
              },
              {
                "id": 140906296,
                "url": "https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...",
                "category": "company",
                "datetime": 1784095786,
                "headline": "Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"
              },
              {
                "id": 140901947,
                "url": "https://finnhub.io/api/news?id=5f3fef99ff0df0cac06252e71b332ffd16257eb940089d3f03c9ff846d60da6c",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "TD Cowen  analyst Ryan Langston   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $211 to $350.",
                "category": "company",
                "datetime": 1784028528,
                "headline": "TD Cowen Maintains Hold on Humana, Raises Price Target to $350"
              },
              {
                "id": 140901948,
                "url": "https://finnhub.io/api/news?id=3c52092a2a30d09e2f4291941a91a1161fec0a8e29e89d8fa52bd0d1ff2215ef",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Truist Securities  analyst David Macdonald   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $320 to $415.",
                "category": "company",
                "datetime": 1784021510,
                "headline": "Truist Securities Maintains Hold on Humana, Raises Price Target to $415"
              },
              {
                "id": 140893488,
                "url": "https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1783995721,
                "headline": "Wells Fargo Upgrades Humana (HUM)"
              },
              {
                "id": 140890161,
                "url": "https://finnhub.io/api/news?id=e25110c78ca2177615e41497f4272b141937d60a5e1b269003abf9d7270f7d7c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and",
                "category": "company",
                "datetime": 1783971281,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 140890023,
                "url": "https://finnhub.io/api/news?id=495aea92af0bbd7e19a383216dfbd22c522dee63025845643456bbfaa14d3c16",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.",
                "category": "company",
                "datetime": 1783965840,
                "headline": "Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch"
              },
              {
                "id": 140890002,
                "url": "https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.",
                "category": "company",
                "datetime": 1783965262,
                "headline": "The Premium On CVS Stock Vs What Its Peers Deliver"
              },
              {
                "id": 140888416,
                "url": "https://finnhub.io/api/news?id=fd4d4d323ca3fedefea2cc6d440ffd8cf63824e0800c451fe6d924a57bcada11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.",
                "category": "company",
                "datetime": 1783960620,
                "headline": "Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?"
              },
              {
                "id": 140885931,
                "url": "https://finnhub.io/api/news?id=d9bd3e5a447e59b21f811bc30301952ad049da7bb5153d18da437fe995ccd6e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "American Express, Biogen upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1783950101,
                "headline": "American Express, Biogen upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 140888858,
                "url": "https://finnhub.io/api/news?id=2ee353ba4819573ae59d8207240fe4802587c3ae7f9647c9333653e00912cd13",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Wells Fargo  analyst Stephen Baxter   upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $227 to $502.",
                "category": "company",
                "datetime": 1783929218,
                "headline": "Wells Fargo Upgrades Humana to Overweight, Raises Price Target to $502"
              },
              {
                "id": 140865405,
                "url": "https://finnhub.io/api/news?id=43b032537d5346775647011af917abc702bf8a42f9ad7ce1513fce3cdf3d5099",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.",
                "category": "company",
                "datetime": 1783707000,
                "headline": "Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?"
              },
              {
                "id": 140864271,
                "url": "https://finnhub.io/api/news?id=2e1f4d2e2bd8a771190b14a8e47325fa8f08b3d3b73ff3f485a97a763923bec7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.",
                "category": "company",
                "datetime": 1783700700,
                "headline": "Is ELV's Capital Allocation Strategy Creating Long-Term Value?"
              },
              {
                "id": 140864272,
                "url": "https://finnhub.io/api/news?id=8cb9ceee7f486eaba0b4c7d9e75a7a6713c50af11938b8057df4ec2e73f044c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.",
                "category": "company",
                "datetime": 1783700580,
                "headline": "Can UNH's Lifestyle Spending Account Redefine Employee Benefits?"
              },
              {
                "id": 140861604,
                "url": "https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.",
                "category": "company",
                "datetime": 1783684540,
                "headline": "UNH Showered Owners With Cash. The Stock Did Not Cooperate"
              },
              {
                "id": 140860584,
                "url": "https://finnhub.io/api/news?id=b0b89f578c00f4ef5ee36881a23109c43fd7c57d2231e57e1adfbc28747b77a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16",
                "category": "company",
                "datetime": 1783683039,
                "headline": "The Main Reason Behind Buying UnitedHealth Before July 16"
              },
              {
                "id": 140860865,
                "url": "https://finnhub.io/api/news?id=3534cd0756dbc13bd4612d305a212cd65ae36ef9141d04b1b4365039c50b020f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1278842473/image_1278842473.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The S&P 500 declined 0.95% as market leadership rotated away from mega-cap tech. Read more here.",
                "category": "company",
                "datetime": 1783671000,
                "headline": "Broadening Market Lifts Moat Stocks In June"
              },
              {
                "id": 140854725,
                "url": "https://finnhub.io/api/news?id=4d4ba33028b72345771b2d6177ef4a48ef6331e93a1f3ef095b421cf04b71092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”",
                "category": "company",
                "datetime": 1783622061,
                "headline": "Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”"
              },
              {
                "id": 140851085,
                "url": "https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.",
                "category": "company",
                "datetime": 1783604827,
                "headline": "The Real Price of UnitedHealth Stock Isn't on Today's Label"
              },
              {
                "id": 140865176,
                "url": "https://finnhub.io/api/news?id=b5b0d6d80e9f8fc9b7209c25c2b2b814f79658f1aba834769155c9e2eafae44d",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "RBC Capital  analyst Ben Hendrix   maintains Humana (NYSE:HUM) with a Sector Perform and raises the price target from $246 to $415.",
                "category": "company",
                "datetime": 1783603928,
                "headline": "RBC Capital Maintains Sector Perform on Humana, Raises Price Target to $415"
              },
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              },
              {
                "id": 140843416,
                "url": "https://finnhub.io/api/news?id=5dd1d143f06f4fa4eb3d3a97880fa22ffc1c5de99e6a64d0a7dcb18a4055d14a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.",
                "category": "company",
                "datetime": 1783524300,
                "headline": "UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?"
              },
              {
                "id": 140834545,
                "url": "https://finnhub.io/api/news?id=2b9ad6b049d73243c2c7d8cc8764c34538c16d53083e94ef5b89809c55698234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.",
                "category": "company",
                "datetime": 1783430767,
                "headline": "Humana Earnings Preview: What to Expect"
              },
              {
                "id": 140830888,
                "url": "https://finnhub.io/api/news?id=7e0083af50961ff361349709b6916fd6b5d1b8e4b89f6a2ba577c788e6b954a8",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Cantor Fitzgerald  analyst Sarah James   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $264 to $300.",
                "category": "company",
                "datetime": 1783410797,
                "headline": "Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300"
              },
              {
                "id": 140822476,
                "url": "https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.",
                "category": "company",
                "datetime": 1783354301,
                "headline": "What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"
              },
              {
                "id": 140819581,
                "url": "https://finnhub.io/api/news?id=ede26e95f8cd574ded4ee784a40075275bfa1057664adeed1fd210da7b21e2f2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208348437/image_2208348437.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.",
                "category": "company",
                "datetime": 1783327970,
                "headline": "CVS Health: The Surprising Healthcare Outlier"
              },
              {
                "id": 140807752,
                "url": "https://finnhub.io/api/news?id=db7dccf806f73313f5852acc19a832bddeba826f9f5173bb131d4479cbbcd12e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]",
                "category": "company",
                "datetime": 1783174832,
                "headline": "Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”"
              },
              {
                "id": 140799596,
                "url": "https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.",
                "category": "company",
                "datetime": 1783081253,
                "headline": "The Unpopular Move That Telegraphed the Elevance Health Stock Surge"
              },
              {
                "id": 140791579,
                "url": "https://finnhub.io/api/news?id=8dc403fbee8db8aad1d942b0a90f0ef7b4aed8b012426ecb0dbfe2b55e9d2556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.",
                "category": "company",
                "datetime": 1782999120,
                "headline": "PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140772839,
                "url": "https://finnhub.io/api/news?id=6a277ca3b6991ab8e80b88b14bee749319d8ff8f2a6c7597e280f0b5c316b8da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (UNH) is likely to report second-quarter earnings above Wall Street's consensus,",
                "category": "company",
                "datetime": 1782828758,
                "headline": "UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says"
              },
              {
                "id": 140772135,
                "url": "https://finnhub.io/api/news?id=7c0b16820ebd282600b26a580e95b5d32062b8fb552556b1e38962e35c874e2a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 30, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.",
                "category": "company",
                "datetime": 1782820800,
                "headline": "The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants"
              },
              {
                "id": 140771643,
                "url": "https://finnhub.io/api/news?id=933974103b907b1d72be4a7f5132c37cde71a5380376053b69d31f5124d9c4b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DarioHealth Corp. (NASDAQ: DRIO) (the \"Company\", \"DarioHealth\" or \"Dario\"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.",
                "category": "company",
                "datetime": 1782819000,
                "headline": "Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships"
              },
              {
                "id": 140774740,
                "url": "https://finnhub.io/api/news?id=bac1556681a38492c41d8ad99cae5880494ce345262ebc615ded85f7f7858fe6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Two-Injectors-Dosing-Pens-For-Subcutaneo.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility and access.",
                "category": "company",
                "datetime": 1782808093,
                "headline": "Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday"
              },
              {
                "id": 140781618,
                "url": "https://finnhub.io/api/news?id=c2b9cf7db5e8e7b511f80cba972d4339f22d420c6b2bd7054751c0b254645eec",
                "image": "https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.",
                "category": "company",
                "datetime": 1782795601,
                "headline": "Medicare will start covering obesity drugs for the first time. Here's what patients should know"
              },
              {
                "id": 140781757,
                "url": "https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e",
                "image": "https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.",
                "category": "company",
                "datetime": 1782760725,
                "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140762586,
                "url": "https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.",
                "category": "company",
                "datetime": 1782744240,
                "headline": "How CenterWell Is Driving Humana's Growth Beyond Insurance"
              },
              {
                "id": 140761652,
                "url": "https://finnhub.io/api/news?id=ec9490d78d2bbdede75602bb26eb289d1c5b1536c79f6283f5756d1080b4670b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.",
                "category": "company",
                "datetime": 1782737415,
                "headline": "2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges"
              },
              {
                "id": 140738020,
                "url": "https://finnhub.io/api/news?id=21eee8397f16e7d74095ad3cf7e8fc458841490e5fdbb2389cbf7c1ad40e1088",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.",
                "category": "company",
                "datetime": 1782488700,
                "headline": "Can Carelon Drive Elevance Health's Future Earnings Growth?"
              },
              {
                "id": 140739246,
                "url": "https://finnhub.io/api/news?id=47ec2a2209086a44ad157e6195ed8a0ffc0e3023569ffaf896991b26b1a9e44d",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1782480916,
                "headline": "4 Health Care Stocks With Whale Alerts In Today’s Session"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 77,
            "discarded_article_count": 69
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.6,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.5,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1440810,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1346350,
              "avg_vol_20": 1338770,
              "avg_vol_30": 1440810,
              "range_pct_10": 0.11214424863494678,
              "range_pct_20": 0.18064833091933807,
              "range_pct_30": 0.19474982033417698,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.934439655471575,
              "dist_to_20d_high": 0.09224023036746869,
              "down_shrink_days": 3,
              "breakout_level_20d": 428.88,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5758374947022551
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.576209709847691,
              "turnoverUsdM": 288.213603403,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 361.4742,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7.2,
            "take_profit_price": 408.786,
            "target_multiplier": 1.6,
            "technical_strength": 1.22,
            "take_profit_percent": 5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.152419419695382,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 13.9229,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.58
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -67.56
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0466
    },
    "kdj": {
      "d": 33.59,
      "j": 4.32,
      "k": 23.84,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 34.13
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 23349800,
      "recentSlope": -64740,
      "previousSlope": 432770
    },
    "rsi": 47.89,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 411.6004,
      "position": "SAR喺價上",
      "distancePct": 5.72,
      "previousTrend": "下降"
    },
    "ma50": 360.8916,
    "macd": {
      "macd": 10.207891051209003,
      "trend": "中性偏多",
      "signal": 13.956996889940186,
      "histogram": -3.7491058387311824
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 397.0235,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.56,
      "score": 2,
      "avgVolume": 1318230,
      "currentVolume": 740300
    },
    "derived": {
      "ma20": 397.0435,
      "ma50": 360.8916,
      "prevClose": 394.5,
      "avgVolume10": 1241550,
      "avgVolume20": 1318230,
      "changePercent": -1.31,
      "avgVolumeForScore": 1318230
    },
    "ma_cross": {
      "ma20": 397.0435,
      "ma50": 360.8916,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 396.3775,
      "prevMa50": 359.0122,
      "spreadPct": 10.02,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 383.0929,
      "upper": 410.9941,
      "position": "中間"
    },
    "rsi_short": 53.89,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.56
    }
  }
}

Raw metrics JSON

{
  "close": 389.32,
  "volume": 740300,
  "changePercent": -1.31
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.HUM · Humana

避免

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 2.8/5 · 較差

Sub-items

資金流 — 6.8/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 5.4/15 · 較差

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 2/20 · 較差

Sub-items

catalyst

details

風險管理 — 5.9/10 · 較差

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 17.6/30 · 較差

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 6/10 · 一般

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON